Related Experiment Videos
Current treatment of chronic heart failure in primary care; still room for improvement
Marije Bosch1, Michel Wensing, J Carel Bakx
1Scientific Institute for Quality of Healthcare, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. marije.bosch@monash.edu
Insights
Treatment for chronic heart failure (CHF) in primary care has improved, particularly beta-blocker use. However, lifestyle advice for CHF patients needs enhancement in primary care settings.
Area of Science:
- Cardiology
- Primary Care Medicine
- Public Health
Background:
- Recent updates to chronic heart failure (CHF) treatment guidelines necessitate understanding current primary care practices.
- Previous studies indicated suboptimal pharmacological and non-pharmacological CHF management in primary care.
Purpose of the Study:
- To assess current pharmacological and non-pharmacological treatment of chronic heart failure (CHF) in primary care.
- To identify areas for improvement in CHF management within the primary care setting.
Main Methods:
- A cross-sectional observational study was conducted.
- A representative sample of 357 patients with CHF from 42 Dutch primary care practices was included.
- Data were collected via medical records and patient/doctor questionnaires.
Main Results:
- The average patient age was 75.7 years, with 53% males; 73% had mild CHF (NYHA class I/II).
- Diuretics were used by 76.5%, ACE inhibitors by 40.6%, ARBs by 20.7%, beta-blockers by 54.6%, and spironolactone by 24.9%.
- Patients with severe CHF were less likely to receive guideline-adherent treatment; 40-60% received lifestyle advice.
Conclusions:
- Evidence-based pharmacotherapy for CHF in primary care has improved post-guideline updates, notably beta-blocker prescription rates.
- Significant opportunities exist to enhance CHF management, particularly in delivering comprehensive lifestyle advice.
- Further implementation of guideline recommendations is crucial for optimizing patient outcomes in primary care.
Unlabelled:
RATIONAL AND AIMS: In recent years, guidelines for treatment of patients with chronic heart failure (CHF) have been updated. Insight in current pharmacological and non-pharmacological treatment of CHF in primary care, which was non-optimal in earlier studies, is limited. We aim to describe current pharmacological and non-pharmacological treatment of CHF in primary care.
Methods:
In this cross-sectional observational study, we included a representative sample of 357 patients diagnosed with CHF from 42 primary care practices in the Netherlands. We combined medical record data with data from patient and doctor questionnaires.
Results:
Mean age of patients was 75.7 years (SD 10.2), 53% were male, and 73% of patients had mild heart failure (New York Heart Association class I or II). 76.5% of patients received diuretics. Angiotensin-converting enzyme inhibitors were prescribed in 40.6% and angiotensin-II receptor blockers in 20.7%; beta-blockers were prescribed to 54.6%, while 24.9% received spironolactone. Patients with more severe heart failure had a lower probability of being treated according to guideline recommendations. Relevant lifestyle advice was given to 40-60% of the patients, depending on the specific lifestyle advice.
Conclusions:
Implementation of evidence-based pharmacotherapy for heart failure in primary care has improved since clinical guidelines have been updated; especially with respect to prescription of beta-blockers. However, there still seems ample room for improvement, as in the case for providing lifestyle advice.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy